▲ BUY
9
/ 10
Conviction
$ Value
$2.0M
Shares
111,111
Price
$18
Filed
Feb 6
▶ Why this score? (9/10)
- ✓ Open market buy (+3)
- ✓ Trade value >= $1.0M (+2)
- ✓ Director (+1)
- ✓ Cluster: 4 insiders buying (+2)
- ✓ Not a 10b5-1 plan (+1)
Insider
Name
FRAZIER KENNETH C
Title
—
CIK
0001181175
Roles
Director
Transaction Details
Transaction Date
2026-02-04
Code
P
Table
Non-Derivative
Ownership
Direct
Equity Swap
No
Shares After
111,111
Filing Info
Other Insiders at EIKN (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
| Column Group IV GP, LP | $38.1M | — | 2026-02-06 |
| Lux Venture Partners V, LLC | $5.0M | — | 2026-02-06 |
| Wolfe Josh | $5.0M | — | 2026-02-06 |
| Foresite Capital Management IV, LLC | $1000K | — | 2026-02-04 |
| FRAZIER KENNETH C | — | — | 2026-03-02 |
|
PERLMUTTER ROGER M
See remarks
|
— | — | 2026-03-02 |
|
Baynes Roy D.
Chief Medical Officer
|
— | — | 2026-03-02 |
| Huffines Robert Luther | — | — | 2026-03-02 |
|
Klobuchar Michael A
Chief Operating Officer
|
— | — | 2026-03-02 |
|
Thorner Benjamin Bruno
See Remarks
|
— | — | 2026-03-02 |
|
Bowie Alfred Lloyd Jr.
Chief Financial Officer
|
— | — | 2026-03-02 |